SpyGlass Pharma SGP
NASDAQ SGP
$34.97 +0.79 (+2.31%)
At close: Nov 11, 2026 · 4:00 PM EST

SpyGlass Pharma (SGP) Cash & Equivalents (2024 - 2026)

Updated

SpyGlass Pharma's Cash & Equivalents came in at $223.14 million for Q2 2026.

Analysis

SpyGlass Pharma (SGP) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, SpyGlass Pharma's Cash & Equivalents was $96.36 million, up 492.3% from FY2024.

  • Going back by year, Cash & Equivalents was $16.27 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 400.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.82 Bn
10 SpyGlass Pharma 1.14 Bn 534.30 Mn - 223.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223.14 Mn
Mar 31, 2026 238.90 Mn
Dec 31, 2025 96.36 Mn
Dec 31, 2024 16.27 Mn
API Access

SpyGlass Pharma Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SGP&period=max&api_key=YOUR_API_KEY